RxDoctor Payments Data

Hannah Culbreth, PA

Physician Assistant · Charleston, SCNPI 1912509803

Payments from drug & device makers

$2,498in general payments, 2019–2025

Across 51 payments — averaging $48.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$2K
  • Biohaven Pharmaceuticals, Inc.$65
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$65
  • Takeda Pharmaceuticals U.S.A., Inc.$53
  • AstraZeneca$49
  • Intercept Pharmaceuticals, Inc.$37
  • plus $210 from 11 others

What the payments were for

  • Travel & lodging$1,45758%
  • Food & beverage$1,04142%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,498 in reported general payments places this provider in the 80th percentile of 1,852 physician assistant providers in South Carolina.

See all physician assistant providers in South Carolina

Medicare billing

Part B allowed, 2024
$14,894
Medicare patients
153
Services billed
203

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
LinzessLinaclotide67$38,123
ZenpepLipase/Protease/Amylase11$11,243
MovantikNaloxegol Oxalate17$7,588
Colestipol Hcl65$5,224
Pantoprazole Sodium305$3,062
Ursodiol21$2,838
Lubiprostone20$2,007
Lansoprazole65$1,515
Dicyclomine Hcl72$1,398
Famotidine118$1,100
Omeprazole57$884
Ondansetron OdtOndansetron50$846
Sucralfate22$564
Metronidazole41$324
Diphenoxylate-AtropineDiphenoxylate Hcl/Atropine15$248

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieLinzess$32$38,12367 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 1,852 physician assistant providers in South Carolina.

Other physician assistant in Charleston

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →